Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- PMID: 12665708
- DOI: 10.1097/01.OGX.0000062966.93819.5B
Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Abstract
Fertility in women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency appears to be reduced. The purpose of this review is to summarize the reported evidence about subfertility in women with CAH and to review the causes of reduced fertility. Compared with a non-CAH female population, pregnancy and live-birth rates are severely reduced in salt-wasting patients, mildly reduced in simple virilizing patients, and normal in nonclassical patients. Several factors have been suggested to contribute to the impaired fertility in CAH females: adrenal overproduction of androgens and progestins (17-hydroxyprogesterone and progesterone), ovarian hyperandrogenism, polycystic ovary syndrome, ovarian adrenal rest tumors, neuroendocrine factors, genital surgery, and psychological factors such as delayed psychosexual development, reduced sexual activity and low maternal feelings. It is obvious that these factors are interrelated. Improving endocrine, surgical, and psychological management could contribute to improving fertility chances in these patients.
Target audience: Obstetricians & Gynecologists, Family Physicians.
Learning objectives: After completion of this article, the reader will be able to define the various types of CAH, to describe the fertility issues in the CAH patients, to outline the various other causes of hyperandrogenism, and to list the treatment options for the patient with CAH.
Similar articles
-
Fertility in patients with congenital adrenal hyperplasia.J Pediatr Endocrinol Metab. 2006 May;19(5):677-85. doi: 10.1515/jpem.2006.19.5.677. J Pediatr Endocrinol Metab. 2006. PMID: 16789634 Review.
-
Puberty and fertility in congenital adrenal hyperplasia.Endocr Dev. 2005;8:54-66. doi: 10.1159/000084093. Endocr Dev. 2005. PMID: 15722617 Review.
-
Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate.Clin Endocrinol (Oxf). 2009 Jun;70(6):833-7. doi: 10.1111/j.1365-2265.2009.03563.x. Epub 2009 Feb 25. Clin Endocrinol (Oxf). 2009. PMID: 19250265
-
Fertility among women with classical congenital adrenal hyperplasia: report of seven cases where treatment was started after 9 years of age.Gynecol Endocrinol. 2008 May;24(5):267-72. doi: 10.1080/09513590801945230. Gynecol Endocrinol. 2008. PMID: 18569031
-
Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.N Engl J Med. 1987 Jan 22;316(4):178-82. doi: 10.1056/NEJM198701223160402. N Engl J Med. 1987. PMID: 3491959
Cited by
-
Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.Eur J Endocrinol. 2016 May;174(5):601-9. doi: 10.1530/EJE-15-1181. Epub 2016 Feb 10. Eur J Endocrinol. 2016. PMID: 26865584 Free PMC article.
-
Novel treatment strategies in congenital adrenal hyperplasia.Curr Opin Endocrinol Diabetes Obes. 2016 Jun;23(3):225-32. doi: 10.1097/MED.0000000000000256. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 27032061 Free PMC article. Review.
-
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.Front Endocrinol (Lausanne). 2022 Dec 12;13:1064024. doi: 10.3389/fendo.2022.1064024. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36578966 Free PMC article. Review.
-
Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.Am J Bioeth. 2012;12(7):3-16. doi: 10.1080/15265161.2012.680533. Am J Bioeth. 2012. PMID: 22694023 Free PMC article.
-
Steroid biomarkers in human adrenal disease.J Steroid Biochem Mol Biol. 2019 Jun;190:273-280. doi: 10.1016/j.jsbmb.2019.01.018. Epub 2019 Jan 29. J Steroid Biochem Mol Biol. 2019. PMID: 30707926 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical